spacer
home > pmps > Autumn 2016
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Autumn 2016

   
Text
PDF
Industry Insight 
Industry Insight

PMPS Industry Advisor Robert Harris discusses the use of smart devices in healthcare today and how the Internet of Things can improve patient adherence and welfare. He picks out a number of articles from this edition that address the steps that pharma is taking in this field.
 
view
download pdf
bullet
Manufacturing
High Potency Drugs

Potent Protection


Knowing how to control and contain potent compounds is imperative, especially as they can be found in over a quarter of drugs around the world. With this number expected to grow, Dr Shabbir Mostafa at Aesica puts forward some of the best methods for handling these materials.
 
view
download pdf
Potent Compounds

Safety First

John Michnick
at Cambrex contemplates contract manufacturers and their conduct of projects comprising highly potent compounds. As demand for these products grows, it is crucial that those working with them are kept safe and experience, he says, is key.
 
view
download pdf
Micronisation

Thinking Small

Elanor Pinto-Cocozza
at Catalent Pharma Solutions discusses a problem that needs to be addressed: the number of drugs that are poorly soluble and permeable in the market. She argues that the answer could be micronisation, with benefits ranging from manufacturing right through to patient compliance.
 
view
download pdf
Machines and Tooling

Time is Pressing

Natoli Engineering Company
’s Robert Sedlock scrutinises the powder die filling process, and how it is hindering the creation of good quality tablets. By analysing each component in the procedure, he reveals ways to overcome the challenges associated with it.
 
view
download pdf
bullet
Cool Chain, Cargo & Logistics
Strategic Partnerships

The Extra Mile

Kamaljit Hunjam
at CEVA Logistics reviews the relationship between a pharma company and its logistics provider. As one of the key links in the supply chain, this affiliation should grow and develop to serve both parties in old and new markets.
 
view
download pdf
Temperature Control

To What Degree?


With many manufacturers now moving towards more structurally complex biotechnological drugs, it is vital to keep these drugs at the correct temperature during storage and transit. Zuellig Pharma’s Darren Wedding believes it is possible to achieve this and keep costs to a minimum.
 
view
download pdf
Transporting Pharmaceuticals

It’s All in the Air


What is the best way to manage the temperature of your pharmaceuticals during transit? Mark Edwards at Modalis provides an overview of the different approaches currently available – including blankets and airline cargo services – which promise to optimise both cost-effectiveness and compliance.
 
view
download pdf
Phase Change Materials

Keeping Cool


With regulators clamping down on temperature excursions, cold chain logistics is becoming more expensive. One way of bringing the cost down is the utilisation of phase change materials, suggest Jamie Chasteen at Cold Chain Technologies and Richard Harrop at Topa Thermal.
 
view
download pdf
Clinical Trial Logistics

The Heat is On


Bringing new products to market is an increasingly expensive endeavour. As companies search for ways to cut costs while executing clinical trials, John Lee at Courier Express examines why they are looking to third-party logistics providers for a viable solution.
 
view
download pdf
bullet
Packaging, Packing & Anti-Counterfeiting
Serialisation Issues

Phasing In


To establish an efficient, compliant and cost-effective supply chain, track and trace requirements have become the norm among logistics companies. Chuck Sailer at Adents explores the importance of serialisation and discusses why managing overall equipment effectiveness is more important than ever before.
 
view
download pdf
Electronic Packaging

A Smart Approach


The Internet of Things technology is continuously advancing – but how can the packaging sector leverage such innovation? Roosje Watson at the Centre for Process Innovation uncovers the benefits of this combination for the manufacturer, supply chain and, ultimately, the consumer.
 
view
download pdf
Patient Adherence

Do You Remember?


New legislation, such as the EU Falsified Medicines Directive, has increased the amount of requirements in serialisation and tamper verification. Essentra’s Rupert Taylor observes the effect this can have on patient compliance, and shares advice on how to avoid the resulting financial strain.
 
view
download pdf
bullet
MACHINERY
Asset Management

Second-User Revolution

EquipNet’s Ben Potenza
proposes one solution to save money on equipment: buying second-hand. As the advantages are fast becoming recognised in such a rapidly evolving marketplace, he homes in on how purchasing used assets can help with the demand for reduced costs and time to market.
 
view
download pdf
bullet
the end of the line
End of the Line

Click and Collect


What are the dangers of buying pharmaceutical products on the internet? Robert Harris looks at the steps needed to prohibit counterfeit medicines from being bought online.
 
view
download pdf
bullet
CLINICAL TRIAL SUPPLIES & LOGISTICS
Comparator Drugs

Source and Supply


As clinical trials become more expensive – averaging around $36,500 per patient – Durbin’s Robert Donnell looks at the different ways to obtain comparator drugs. Covering both acquisition directly from the manufacturer and sourcing from the open market, he ponders the good and the bad points of each method.
 
view
download pdf
bullet
PATIENT COMPLIANCE
Patient Centricity

At the Centre


As a result of headlines highlighting drug pricing in the market, patient centricity is the current buzzword of the pharma industry. Justin Schroeder at PCI Pharma Services explores why patients, rather than the product, should be the focus.
 
view
download pdf
   
spacer
Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August and November

News and Press Releases

Synpromics Announces Gene Therapy Research Partnership with Solid Biosciences

Edinburgh, UK – September 20th, 2017 - Synpromics Ltd, the leader in gene control, today announces a new research partnership with Solid Biosciences, LLC. Under the terms of the agreement, Synpromics will provide Solid Biosciences access to a set of key muscle-selective promoter candidates to be used in the development of new treatment options for Duchenne muscular dystrophy (DMD).
More info >>

White Papers

Environmental Factors in Data Centres

Dycem

In addition to temperature and humidity, there are many more constraints in the environment that increase failure rates, explains Emilio Sapiña of Secure Techincal Rooms.
More info >>

Industry Events

Pharmapack Europe 2018

7-8 February 2018, Hall 7.1, Paris Expo, Porte de Versailles, Paris.

As Europe's dedicated Pharmaceutical Packaging and Drug Delivery event, Pharmapack is the industry's go-to place to kick-off the year.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement